Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Classical hematology 2

Conditions

Venous Thrombosis 3Pulmonary Embolism 3Neoplasms 3Venous Thromboembolism 2Thrombosis 1Myeloproliferative Disorders 1

Interventions

Dalteparin 9apixaban 7Tinzaparin 5Enoxaparin 5Rivaroxaban 3Dabigatran 3Warfarin 2Heparin, Low-Molecular-Weight 2Fondaparinux 2perflutren 1enoxaparin sodium 1edoxaban 1bemiparin 1Sulfur Hexafluoride 1Rosuvastatin Calcium 1Phenprocoumon 1Nephrectomy 1Nadroparin 1Hospitals 1Heparin 1Fluorodeoxyglucose F18 1Educational Status 1Deoxyribonucleases 1Aspirin 1Acenocoumarol 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Pulmonary Embolism × Dabigatran × Clear all
NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01727427 2019-08-08

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

G. d'Annunzio University

Completed
695 enrolled

Neoplasms, Pulmonary Embolism

NCT03240120 2019-04-17

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

The University of Hong Kong

Phase 3 Unknown
99 enrolled
Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡